Through its three business segments – Healthcare, Materials, and Imaging – Fujifilm is leveraging technology and innovation to build a healthier and more sustainable world.
In the Healthcare segment, we provide cutting-edge products and services worldwide that address unmet medical needs, improve access to medical care, and detect diseases in their early stages. In our medical diagnostic segment, we are creating new value with our extensive lineup of CT, MRI, X-ray diagnostic equipment, ultrasound and endoscopy systems based on highly advanced image-processing, AI, and proprietary technologies. Furthermore, our Contract Development and Manufacturing Organization (CDMO) business for biologics is facilitating a stable supply of high-quality biopharmaceuticals and promoting process development and manufacture of gene and cell therapy drugs in the field of advanced medical treatment.
In the Materials segment, we contribute to creating a safe and secure society in today’s era of digital transformation (DX). We are developing advanced materials essential for manufacturing cutting-edge semiconductors. We are expanding our product lineup in order to contribute to the development of 5G, AI, autonomous driving, and other leading-edge technologies, and also promoting the development of high value-added products that utilize our technology, such as display materials, industrial materials and equipment.
In the Imaging segment, we enrich lives through photography by developing and bringing to market high-quality, high-performance products and services, ranging from high-end mirrorless digital cameras to printing services and instant photo systems that let users enjoy printing photos on-the-spot.
The world faces many challenges. The Fujifilm Group will continue to strive for sustainable growth and increased corporate value through its business activities, while aiming to contribute to the sustainable development of society.
Teiichi Goto
President, Representative Director & Chief Executive Officer